Serial #97806670
LIVE

Serial Number

97806670

Owner

Amphista Therapeutics Limited

Attorney

Rob LeBlanc

Filing Date

Feb 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97806670 Trademark

Serial Number: 97806670 • Registration: 7436832

Serial #97806670 is a trademark filed by Amphista Therapeutics Limited on February 22, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Amphista Therapeutics Limited (5 trademarks)

Bahnhofstrasse 52
Zurich CH-8001 , CH

Entity Type: 11

Trademark Details

Filing Date

February 22, 2023

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Pharmaceuticals, medicinal and veterinary preparations for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or medical research use

Scientific and technological services, namely, scientific analysis, testing, engineering, development, research, and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medicinal preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological substances and chemicals testing; research and development in the pharmaceutical, chemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 22, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 22, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 22, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 22, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 22, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 8, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 20, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 14, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2023 NWOS
NEW APPLICATION ENTERED
Feb 25, 2023 NWAP